18 results on '"Sizemore, Lindsey"'
Search Results
2. Using Public Health Surveillance Data to Determine Hepatitis C Virus Exposure Among Live-Born Infants in Tennessee, 2013-2017.
- Author
-
Wingate, Heather, Sizemore, Lindsey, Black, Jennifer, Heth, Zachary, Talley, Pamela, Patrick, Stephen W., and Wester, Carolyn
- Subjects
- *
HEPATITIS C transmission , *PUBLIC health surveillance , *MOTHERS , *PUBLIC health , *HEPATITIS viruses , *MOTHER-infant relationship , *LONGITUDINAL method - Abstract
Objective: Maternal hepatitis C virus (HCV) infection reported on birth certificates has been shown to underestimate HCV infection. We sought to determine the usefulness of HCV surveillance data for (1) quantifying the number of HCV-positive reproductive-aged women with a live birth, (2) comparing maternal HCV surveillance data with reported HCV infection status on birth certificates, and (3) delineating past versus current maternal infection to identify true perinatal exposures. Methods: We extracted data from January 1, 2013, through December 31, 2017, on birth certificate indication of HCV exposure from the Tennessee Birth Statistical File, and we ascertained indication of HCV exposure by using laboratory data from the Tennessee National Electronic Disease Surveillance System (NEDSS) Base System (NBS). We conducted a sensitivity analysis comparing birth certificate indication of HCV exposure with HCV laboratory data to determine whether true perinatal exposure had occurred. Results: During the study period, 6731 mothers with live births in Tennessee reported having HCV infection during pregnancy: 3295 (49.0%) had both laboratory and birth certificate indication of HCV infection, 2130 (31.6%) had indication of HCV infection on the laboratory report only, and 1306 (19.4%) had indication of HCV infection on the birth certificate only. Conclusions: Using data from a public health HCV surveillance system with birth certificate data may improve the identification of HCV-infected pregnant women and perinatally exposed infants. Surveillance systems that include complete reporting of all HCV RNA results can be used to distinguish past from present maternal HCV infection to focus limited public health resources on currently infected mothers and their exposed infants. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Assessment of Tennessee's county-level vulnerability to hepatitis C virus and HIV outbreaks using socioeconomic, healthcare, and substance use indicators.
- Author
-
Vakili, Jessica, Sizemore, Lindsey, Rebeiro, Peter F., Tyndall, Ben, Talley, Pamela, Whaley, Kristyn, and Brantley, Meredith
- Subjects
- *
DRUG abuse , *SUBSTANCE abuse , *HEPATITIS C virus , *HIV , *BIRTH rate , *HEALTH services accessibility - Abstract
Background: Human immunodeficiency virus (HIV), hepatitis C virus (HCV), and injection drug use are syndemic in the central Appalachian states. In Tennessee (TN), declines in HIV among persons who inject drugs (PWID) stalled, and HCV infection rates increased significantly from 2013–2017. To better target strategies to address the syndemic, county-level socioeconomic, opioid use, access to healthcare, and health factors were modeled to identify indicators predictive of vulnerability to an HIV/HCV outbreak among PWID in TN. Methods: Newly reported chronic HCV cases among persons aged 13–39 years in 2016–2017 were used as a proxy for county-level HIV/HCV vulnerability among TN's 95 counties. Seventy-five publicly available county-level measures from 2016–2017 were collected and reduced through multiple dimension reduction techniques. Negative binomial regression identified indicators associated with HCV which were used to calculate county-level vulnerability to a local HIV/HCV outbreak. Results: Thirteen county-level indicators were identified as strongly predictive of HIV/HCV vulnerability with the statistically significant indicators being percentage of the population aged 20–44 years, per capita income, teen birth rate, percentage of clients in TDMHSAS-funded opioid treatment and recovery, syphilis case rate, and percentage of homes with at least one vehicle. Based on the 13 indicators, we identified the distribution of vulnerability to an HIV/HCV outbreak among TN's counties. Eleven high vulnerability counties were identified, with the preponderance located in east and middle TN. Conclusion: This analysis identified the county-level factors most associated with vulnerability to an HIV/HCV outbreak among PWID in TN. These results, alongside routine surveillance, will guide targeted prevention and linkage to care efforts for the most vulnerable communities. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Using an Established Outbreak Response Plan and Molecular Epidemiology Methods in an HIV Transmission Cluster Investigation, Tennessee, January–June 2017.
- Author
-
Sizemore, Lindsey, Fill, Mary-Margaret, Mathieson, Samantha A., Black, Jennifer, Brantley, Meredith, Cooper, Kelly, Garrett, Joy, Switzer, William M., Peters, Philip J., and Wester, Carolyn
- Subjects
- *
DIAGNOSIS of HIV infections , *HIV infection genetics , *HIV infection risk factors , *HIV infection transmission , *HIV infection epidemiology , *INTRAVENOUS drug abuse , *CLUSTER analysis (Statistics) , *DISEASE outbreaks , *HEPATITIS C , *HETEROSEXUALITY , *INTERPROFESSIONAL relations , *INTERVIEWING , *MOLECULAR epidemiology , *MOLECULAR pathology , *PUBLIC health , *PUBLIC health surveillance , *RISK assessment , *SELF-evaluation , *STRATEGIC planning , *MEN who have sex with men , *DISEASE complications - Abstract
Introduction: In April 2017, the Tennessee Department of Health (TDH) was notified of an increase in the number of persons newly diagnosed with HIV in eastern Tennessee in the same month. Two were identified as persons with a history of injection drug use (IDU) and named each other as syringe-sharing partners, prompting an investigation into a possible HIV cluster among persons with a history of IDU. Materials and Methods: TDH and public health staff members in eastern Tennessee collaborated to implement procedures outlined in TDH's HIV/hepatitis C virus (HCV) Outbreak Response Plan, including conducting enhanced interviewing and using a preestablished database for data collection and management. To complement contact tracing and enhanced interviewing, TDH partnered with the Centers for Disease Control and Prevention to conduct molecular HIV analyses. Results: By June 27, 2017, the investigation had identified 31 persons newly diagnosed with HIV infection; 8 (26%) self-reported IDU, 4 of whom were also men who have sex with men (MSM). Of the remaining 23 persons newly diagnosed with HIV infection, 10 were MSM who did not report IDU, 9 reported high-risk heterosexual contact, and 4 had other or unknown risk factors. Molecular analysis of the 14 HIV-1 polymerase genes (including 7 of the 8 persons self-reporting IDU) revealed 3 distinct molecular clusters, one of which included 3 persons self-reporting IDU. Practice Implications: This investigation highlights the importance of implementing an established Outbreak Response Plan and using HIV molecular analyses in the event of a transmission cluster or outbreak investigations. Future HIV outbreak surveillance will include using Global Hepatitis Outbreak Surveillance Technology to identify HCV gene sequences as a potential harbinger for HIV transmission networks. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Prevalence of hepatitis C virus among fatal drug overdoses in Tennessee: an analysis using 2019–2020 Tennessee State Unintentional Drug Overdose Reporting System Data.
- Author
-
Korona-Bailey, Jessica, Riley Saint, Sarah, Sizemore, Lindsey, Wingate, Heather, Shoup, Paula, Hawes, Amy, and Mukhopadhyay, Sutapa
- Subjects
- *
DRUG overdose , *HEPATITIS C virus , *DRUG abuse , *COMMUNICABLE diseases - Abstract
Given the nature of the co-occurring epidemics of hepatitis C virus (HCV) and fatal stimulant overdose, we sought to assess the prevalence of HCV among opioid and stimulant-positive overdoses. We conducted a cross-sectional study to examine the prevalence of HCV among fatal drug overdoses in Tennessee using 2019–2020 data from the State Unintentional Drug Overdose Reporting System. We defined history of HCV using surveillance data and autopsy reports. Descriptive statistics were calculated for circumstances of overdose deaths for different categories of opioid and stimulant positivity on toxicology. Between 2019 and 2020, 3570 unintentional or undetermined drug overdose deaths occurred in Tennessee with an available autopsy. History of HCV was found in 24.6% of deaths. When assessing different involvement between stimulants and opioids, the highest prevalence of HCV was found for deaths where methamphetamine and opioids were present in toxicology (35.4%). Scene evidence of injection drug use occurred more frequently among decedents with a history of HCV (P <.0001). This analysis while descriptive highlights the importance of linking datasets to enhance infectious disease and drug overdose surveillance. Partnership between communicable disease and drug overdose surveillance teams should continue to identify relationships between disease and drug overdose and strengthen the evidence to tailor crucial treatment and prevention activities. • Stimulants are involved in half of the fatal drug overdoses in Tennessee. • HCV prevalence of 35.4% in decedents with methamphetamine and opioid on toxicology. • Scene evidence of injection drug use was found in 50.7% of SUDORS cases with HCV. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Birth Outcomes Among People with Hepatitis C in Pregnancy — Three U.S. States, 2018–2021.
- Author
-
Woodworth, Kate R., Newton, Suzanne M., Tannis, Ayzsa, Reynolds, Megan R., Olsen, Emily O., Sizemore, Lindsey, Wingate, Heather, Orkis, Lauren, Reynolds, Bethany, Longcore, Nicole, Thomas, Nadia, Kim, Shin Y., Panagiotakopoulos, Lakshmi, Wester, Carolyn, Delman, Dana Meaney, Gilboa, Suzanne M., and Tong, Van T.
- Subjects
- *
HEPATITIS C diagnosis , *SUBSTANCE abuse , *PUBLIC health surveillance , *SMALL for gestational age , *NEONATAL abstinence syndrome , *RESEARCH funding , *PREMATURE infants , *PREGNANCY outcomes , *PREGNANT women , *ATTITUDES of mothers , *NEONATAL intensive care , *DESCRIPTIVE statistics , *PREGNANCY complications , *HEPATITIS C , *DATA analysis software , *CONFIDENCE intervals , *DISEASE risk factors , *DISEASE complications , *PREGNANCY - Abstract
Introduction: There are limited and conflicting data regarding the impact of hepatitis C in pregnancy on adverse birth outcomes. Methods: Using the Surveillance for Emerging Threats to Pregnant People and Infants Network (SET-NET), a large surveillance cohort, we describe birth outcomes among a cohort of people with HCV in pregnancy in total and by reported substance use. Results: Among 1418 infants, 89% were born to people with reported substance use during pregnancy. The proportion born preterm was 20%, 13% were small-for-gestational age and 34% of term infants required intensive care. Conclusions: Assessments of recent changes to recommendations for HCV screening in pregnancy should evaluate the impact on maternal access to care for both HCV treatment as well as comorbidities such as substance use disorder which may contribute to adverse birth outcomes. Significance: Incidence of hepatitis C in pregnancy is increasing. Prematurity, small-for-gestational age, and intensive care unit admission were common among this surveillance cohort of infants born to people with hepatitis C in pregnancy with high frequency of substance use. Assessments of recent changes to recommendations for HCV screening in pregnancy should evaluate the impact on maternal access to care for both HCV treatment as well as comorbidities such as substance use disorder which may contribute to adverse birth outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Trends and Disparities in Mortality and Progression to AIDS in the Highly Active Antiretroviral Therapy Era: Tennessee, 1996–2016.
- Author
-
Rebeiro, Peter F., Pettit, April C., Sizemore, Lindsey, Mathieson, Samantha A., Wester, Carolyn, Kipp, Aaron, Shepherd, Bryan E., and Sterling, Timothy R.
- Subjects
- *
MORTALITY , *HIV-positive persons , *MORTALITY of AIDS patients , *HIGHLY active antiretroviral therapy , *HEALTH equity , *DIAGNOSIS of HIV infections , *DEATH rate , *AIDS , *AIDS risk factors , *BLACK people , *CONFIDENCE intervals , *HETEROSEXUALITY , *HISPANIC Americans , *HIV infections , *PUBLIC health surveillance , *REGRESSION analysis , *SEX distribution , *SUBSTANCE abuse , *WHITE people , *TREATMENT effectiveness , *HUMAN services programs , *PROPORTIONAL hazards models , *DISEASE progression , *ODDS ratio ,MORTALITY risk factors - Abstract
Objectives. To use statewide surveillance data to examine trends and disparities in mortality and progression from HIV to AIDS comprehensively in Tennessee over the past 20 years. Methods. Individuals diagnosed with HIV in Tennessee from 1996 to 2016 were identified through the Tennessee Department of Health Enhanced HIV/AIDS Reporting System. Clinical AIDS and all-cause mortality were the outcomes. Cox regression yielded adjusted hazard ratios (AHRs) for death and competing risk regression yielded adjusted subhazard ratios (SHRs) for AIDS, with death as the competing event. Results. Individuals with a history of heterosexual contact (AHR = 1.20; 95% confidence interval [CI] = 1.12, 1.29) and injection drug use (AHR = 1.27; 95% CI = 1.18, 1.38) had increased hazards of death relative to those with a history of male-to-male sexual contact. Hazards of death were lower among White (AHR = 0.79; 95% CI = 0.73, 0.85) and Hispanic (AHR = 0.50; 95% CI = 0.40, 0.63) individuals than among Black individuals. Those with heterosexual contact (SHR = 1.20; 95% CI = 1.12, 1.29) and injection drug use (SHR = 1.27; 95% CI = 1.18, 1.38) had a greater risk of AIDS than those with male-to-male sexual contact. White individuals (SHR = 0.85; 95% CI = 0.81, 0.90) had a lower risk of AIDS than Black individuals, and female individuals (SHR = 0.84; 95% CI = 0.79, 0.90) had a lower risk than male individuals. Conclusions. The trends, disparities, and outcomes assessed in our study will inform HIV testing and care linkage program design and implementation in Tennessee. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. Frequency of Children Diagnosed with Perinatal Hepatitis C, United States, 2018-2020.
- Author
-
Newton, Suzanne M., Woodworth, Kate R., Chang, Daniel, Sizemore, Lindsey, Wingate, Heather, Pinckney, Leah, Osinski, Anthony, Orkis, Lauren, Reynolds, Bethany D., Carpentieri, Cynthia, Halai, Umme-Aiman, Caleb Lyu, Longcore, Nicole, Thomas, Nadia, Wills, Aprielle, Akosa, Amanda, Olsen, Emily O'Malley, Panagiotakopoulos, Lakshmi, Thompson, Nicola D., and Gilboa, Suzanne M.
- Subjects
- *
HEPATITIS C , *DIAGNOSIS , *PUBLIC health - Abstract
We describe hepatitis C testing of 47 (2%) of 2,266 children diagnosed with perinatal hepatitis C who were exposed during 2018-2020 in 7 jurisdictions in the United States. Expected frequency of perinatal transmission is 5.8%, indicating only one third of the cases in this cohort were reported to public health authorities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Tennessee's In-state Vulnerability Assessment for a "Rapid Dissemination of Human Immunodeficiency Virus or Hepatitis C Virus Infection" Event Utilizing Data About the Opioid Epidemic.
- Author
-
Rickles, Michael, Rebeiro, Peter F, Sizemore, Lindsey, Juarez, Paul, Mutter, Mitchell, Wester, Carolyn, and McPheeters, Melissa
- Subjects
- *
HEPATITIS C risk factors , *HIV infection risk factors , *HIV infection epidemiology , *EPIDEMICS , *HEPATITIS C , *MEDICAL prescriptions , *NARCOTICS , *POISSON distribution , *DISEASE incidence , *PSYCHOLOGICAL vulnerability - Abstract
Background. Knowing which factors contribute to county-level vulnerability to a human immunodeficiency virus (HIV)/hepatitis C virus (HCV) outbreak, and which counties are most vulnerable, guides public health and clinical interventions. We therefore examined the impact of locally available indicators related to the opioid epidemic on prior national models of HIV/HCV outbreak vulnerability. Methods. Tennessee's 95 counties were the study sample. Predictors from 2012 and 2013 were used, mirroring prior methodology from the US Centers for Disease Control and Prevention (CDC). Acute HCV incidence was the proxy measure of county-level vulnerability. Seventy-eight predictors were identified as potentially predictive for HIV/HCV vulnerability. We used multiple dimension reduction techniques to determine predictors for inclusion and Poisson regression to generate a composite index score ranking county-level vulnerability for HIV/HCV. Results. There was overlap of high-risk counties with the national analysis (25 of 41 counties). The distribution of vulnerability reinforces earlier research indicating that eastern Tennessee is at particularly high risk but also demonstrates that the entire state has high vulnerability. Conclusions. Prior research placed Tennessee among the top states for opioid prescribing, acute HCV infection, and greatest risk for an HIV/HCV outbreak. Given this confluence of risk, the Tennessee Department of Health expanded upon prior work to include more granular, local data, including on opioid prescribing. We also explored nonfatal and fatal overdoses. The more complete statewide view of risk generated, not only in eastern counties but also in the western corridor, will enable local officials to monitor vulnerability and better target resources. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Low hepatitis C antibody screening rates among an insured population of Tennessean Baby Boomers.
- Author
-
Carlucci, James G., Farooq, Syeda A., Sizemore, Lindsey, Rickles, Michael, Cosley, Brandon, McCormack, Leigh, and Wester, Carolyn
- Subjects
- *
CHRONIC hepatitis C , *PUBLIC health , *MEDICAL microbiology , *LIVER disease etiology , *ANTIVIRAL agents , *CLINICAL trials , *THERAPEUTICS - Abstract
Introduction: Chronic Hepatitis C Virus (HCV) infection is common and can cause liver disease and death. Persons born from 1945 through 1965 ("Baby Boomers") have relatively high prevalence of chronic HCV infection, prompting recommendations that all Baby Boomers be screened for HCV. If chronic HCV is confirmed, evaluation for antiviral treatment should be performed. Direct-acting antivirals can cure more than 90% of people with chronic HCV. This sequence of services can be referred to as the HCV "cascade of cure” (CoC). The Tennessee (TN) Department of Health (TDH) and a health insurer with presence in TN aimed to determine the proportion of Baby Boomers who access HCV screening services and appropriately navigate the HCV CoC in TN. Methods: TDH surveillance data and insurance claim records were queried to identify the cohort of Baby Boomers eligible for HCV testing. Billing codes and pharmacy records from 2013 through 2015 were used to determine whether HCV screening and other HCV-related services were provided. The proportion of individuals accessing HCV screening and other steps along the HCV CoC was determined. Multivariable analyses were performed to identify factors associated with HCV screening and treatment. Results: Among 501,388 insured Tennessean Baby Boomers, 7% were screened for HCV. Of the 40,019 who received any HCV-related service, 86% were screened with an HCV antibody test, 20% had a confirmatory HCV PCR, 9% were evaluated for treatment, and 4% were prescribed antivirals. Hispanics were more likely to be screened and treated for HCV than non-Hispanic whites. HCV screening was more likely to occur in the Nashville-Davidson region than in other regions of TN, but there were regional variations in HCV treatment. Conclusions: Many insured Tennessean Baby Boomers do not access HCV screening services, despite national recommendations. Demographic and regional differences in uptake along the HCV CoC should inform public health interventions aimed at mitigating the effects of chronic HCV. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Six-Month Outcomes of Infants Born to People With SARS-CoV-2 in Pregnancy.
- Author
-
Gosdin, Lucas, Wallace, Bailey, Lanzieri, Tatiana M., O'Malley Olsen, Emily, Lewis, Elizabeth L., Chang, Daniel J., Khuwaja, Salma, Chicchelly, Sarah, Ojo, Kristen D., Lush, Mamie, Heitner, Daniel, Longcore, Nicole D., Delgado-López, Camille, Humphries, Brian K., Sizemore, Lindsey, Mbotha, Deborah, Hall, Aron J., Ellington, Sascha, Gilboa, Suzanne M., and Tong, Van T.
- Subjects
- *
MATERNAL exposure , *COVID-19 , *CONFIDENCE intervals , *ACQUISITION of data , *PREGNANCY outcomes , *RISK assessment , *HOSPITAL care , *MEDICAL records , *DESCRIPTIVE statistics , *BREASTFEEDING , *RESEARCH funding , *POSTNATAL care , *INFANT mortality - Abstract
OBJECTIVES: To assess the 6-month incidence of laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, postnatal care, hospitalization, and mortality among infants born to people with laboratory-confirmed SARS-CoV-2 infection during pregnancy by timing of maternal infection. METHODS: Using a cohort of liveborn infants from pregnancies with SARS-CoV-2 infections in the year 2020 from 10 United States jurisdictions in the Surveillance for Emerging Threats to Mother and Babies Network, we describe weighted estimates of infant outcomes from birth through 6 months of age from electronic health and laboratory records. RESULTS: Of 6601 exposed infants with laboratory information through 6 months of age, 1.0% (95% confidence interval: 0.8-1.1) tested positive, 19.1% (17.5-20.6) tested negative, and 80.0% (78.4-81.6) were not known to be tested for SARS-CoV-2. Among those ≤14 days of age, SARS-CoV-2 infection occurred only with maternal infection ≤14 days before delivery. Of 3967 infants with medical record abstraction, breastmilk feeding initiation was lower when maternal infection occurred ≤14 days before delivery compared with >14 days (77.6% [72.5-82.6] versus 88.3% [84.7-92.0]). Six-month all-cause hospitalization was 4.1% (2.0-6.2). All-cause mortality was higher among infants born to people with infection ≤14 days (1.0% [0.4-1.6]) than >14 days (0.3% [0.1-0.5]) before delivery. CONCLUSIONS: Results are reassuring, with low incidences of most health outcomes examined. Incidence of infant SARS-CoV-2, breastmilk feeding initiation, and all-cause mortality differed by timing of maternal infection. Strategies to prevent infections and support pregnant people with coronavirus disease 2019 may improve infant outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Breast Milk Feeding of Infants at Birth Among People With Confirmed SARS-CoV-2 Infection in Pregnancy: SET-NET, 5 States, March 29, 2020–December 31, 2020.
- Author
-
Lewis, Elizabeth L., Smoots, Ashley N., Woodworth, Kate R., Olsen, Emily O'Malley, Roth, Nicole M., Yazdy, Mahsa, Shephard, Hanna, Sizemore, Lindsey, Wingate, Heather, Dzimira, Paula, Reynolds, Bethany, Lush, Mamie, Fuchs, Erika L., Ojo, Kristen, Siebman, Sam, Hall, Aron J., Azziz-Baumgartner, Eduardo, Perrine, Cria, Hsia, Jason, and Ellington, Sascha
- Subjects
- *
MATERNAL health services , *COVID-19 , *CONFIDENCE intervals , *RETROSPECTIVE studies , *CHILDREN'S accident prevention , *BREASTFEEDING , *HOSPITAL care , *DESCRIPTIVE statistics , *DISEASE prevalence , *DELIVERY (Obstetrics) , *LONGITUDINAL method - Abstract
Objectives. To describe prevalence of breast milk feeding among people with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and examine associations between breast milk feeding, timing of maternal infection before delivery, and rooming-in status during delivery hospitalization. Methods. We performed a retrospective cohort study using data from Massachusetts, Minnesota, Nebraska, Pennsylvania, and Tennessee of whether people with confirmed SARS-CoV-2 infection during pregnancy in 2020 initiated breast milk feeding at birth. Results. Among 11 114 (weighted number) people with SARS-CoV-2 infection in pregnancy, 86.5% (95% confidence interval [CI] = 82.4%, 87.6%) initiated breast milk feeding during birth hospitalization. People with infection within 14 days before delivery had significantly lower prevalence of breast milk feeding (adjusted prevalence ratio [APR] = 0.88; 95% CI = 0.83, 0.94) than did those with infection at least 14 days before delivery. When stratified by rooming-in status, the association between timing of infection and breast milk feeding remained only among infants who did not room in with their mother (APR = 0.77; 95% CI = 0.68, 0.88). Conclusions. Pregnant and postpartum people with SARS-CoV-2 infection should have access to lactation support and be advised about the importance of breast milk feeding and how to safely feed their infants in the same room. (Am J Public Health. 2022;112(S8):S787–S796. https://doi.org/10.2105/AJPH.2022.307023) [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. SARS‐CoV‐2 infections among neonates born to pregnant people with SARS‐CoV‐2 infection: Maternal, pregnancy and birth characteristics.
- Author
-
Olsen, Emily O'Malley, Roth, Nicole M., Aveni, Kathryn, Santos, Pauline, Sizemore, Lindsey, Halai, Umme‐Aiman, Nestoridi, Eirini, Barton, Jerusha Elana, Mobley, Evan, Siebman, Samantha, Fussman, Chris, Mbotha, Deborah, Dzimira, Paula, Silcox, Kristin M., Khuwaja, Salma, Roscom, Danacamile, Lush, Mamie, Chicchelly, Sarah, Delgado‐López, Camille, and Schlosser, Levi
- Abstract
Background: Multiple reports have described neonatal SARS‐CoV‐2 infection, including likely in utero transmission and early postnatal infection, but published estimates of neonatal infection range by geography and design type. Objectives: To describe maternal, pregnancy and neonatal characteristics among neonates born to people with SARS‐CoV‐2 infection during pregnancy by neonatal SARS‐CoV‐2 testing results. Methods: Using aggregated data from the Surveillance for Emerging Threats to Mothers and Babies Network (SET‐NET) describing infections from 20 January 2020 to 31 December 2020, we identified neonates who were (1) born to people who were SARS‐CoV‐2 positive by RT‐PCR at any time during their pregnancy, and (2) tested for SARS‐CoV‐2 by RT‐PCR during the birth hospitalisation. Results: Among 28,771 neonates born to people with SARS‐CoV‐2 infection during pregnancy, 3816 (13%) underwent PCR testing and 138 neonates (3.6%) were PCR positive. Ninety‐four per cent of neonates testing positive were born to people with infection identified ≤14 days of delivery. Neonatal SARS‐CoV‐2 infection was more frequent among neonates born preterm (5.7%) compared to term (3.4%). Neonates testing positive were born to both symptomatic and asymptomatic pregnant people. Conclusions: Jurisdictions reported SARS‐CoV‐2 RT‐PCR results for only 13% of neonates known to be born to people with SARS‐CoV‐2 infection during pregnancy. These results provide evidence of neonatal infection identified through multi‐state systematic surveillance data collection and describe characteristics of neonates with SARS‐CoV‐2 infection. While perinatal SARS‐CoV‐2 infection was uncommon among tested neonates born to people with SARS‐CoV‐2 infection during pregnancy, nearly all cases of tested neonatal infection occurred in pregnant people infected around the time of delivery and was more frequent among neonates born preterm. These findings support the recommendation for neonatal SARS‐CoV‐2 RT‐PCR testing, especially for people with acute infection around the time of delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Sensitivity of Pregnancy Field on the COVID-19 Case Report Form Among Pregnancies Completed Through December 31, 2020: Illinois and Tennessee.
- Author
-
Manning, Susan E., Bennett, Amanda, Ellington, Sascha, Goyal, Sonal, Harvey, Elizabeth, Sizemore, Lindsey, and Wingate, Heather
- Subjects
- *
PUBLIC health surveillance , *PUBLIC health laws , *MOTHERS , *HEALTH policy , *COVID-19 , *DURATION of pregnancy , *TIME , *RACE , *POPULATION geography , *DOCUMENTATION , *PERINATAL death , *MEDICAL protocols , *BIRTH certificates , *DESCRIPTIVE statistics , *ETHNIC groups , *PRENATAL care , *COLLECTION & preservation of biological specimens , *COVID-19 pandemic , *DEATH certificates , *INSURANCE , *EDUCATIONAL attainment - Abstract
Purpose: The considerable volume of infections from SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has made it challenging for health departments to collect complete data for national disease reporting. We sought to examine sensitivity of the COVID-19 case report form (CRF) pregnancy field by comparing CRF data to the gold standard of CRF data linked to birth and fetal death certificates. Description: CRFs for women aged 15–44 years with laboratory-confirmed SARS-CoV-2 infection were linked to birth and fetal death certificates for pregnancies completed during January 1–December 31, 2020 in Illinois and Tennessee. Among linked records, pregnancy was considered confirmed for women with a SARS-CoV-2 specimen collection date on or prior to the delivery date. Sensitivity of the COVID-19 CRF pregnancy field was calculated by dividing the number of confirmed pregnant women with SARS-CoV-2 infection with pregnancy indicated on the CRF by the number of confirmed pregnant women with SARS-CoV-2 infection. Assessment: Among 4276 (Illinois) and 2070 (Tennessee) CRFs that linked with a birth or fetal death certificate, CRF pregnancy field sensitivity was 45.3% and 42.1%, respectively. In both states, sensitivity varied significantly by maternal race/ethnicity, insurance, trimester of prenatal care entry, month of specimen collection, and trimester of specimen collection. Sensitivity also varied by maternal education in Illinois but not in Tennessee. Conclusion: Sensitivity of the COVID-19 CRF pregnancy field varied by state and demographic factors. To more accurately assess outcomes for pregnant women, jurisdictions might consider utilizing additional data sources and linkages to obtain pregnancy status. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Timing of Positive Hepatitis C Virus Test Results During and 1 Year Before Pregnancy.
- Author
-
Woodworth, Kate R., Newton, Suzanne M., Olsen, Emily O., Tannis, Ayzsa, Sizemore, Lindsey, Wingate, Heather, Orkis, Lauren, Reynolds, Bethany, Longcore, Nicole, Thomas, Nadia, Bocour, Angelica, Wills, Aprielle, Kim, Shin Y., Panagiotakopoulos, Lakshmi, Wester, Carolyn, Delman Meaney, Dana, Gilboa, Suzanne M., and Tong, Van T.
- Subjects
- *
HEPATITIS C virus , *HEPATITIS C , *PREGNANCY - Abstract
The incidence of hepatitis C virus (HCV) infection in reproductive-aged adults quadrupled during the past decade. Hepatitis C can progress to advanced liver disease and be transmitted perinatally. Highly effective curative hepatitis C treatment is available but is not recommended in pregnancy. Using the Surveillance for Emerging Threats to Mothers and Babies Network, we describe timing of positive RNA testing among pregnant people with HCV (HCV RNA detected during or within one year prior to pregnancy). Four US jurisdictions reported 1161 pregnancies during 2018-2021 among people with hepatitis C: 75.9% were multiparous; and 21.4% had their first peri-pregnancy HCV RNA detected prior to pregnancy, indicating potential missed treatment opportunities to improve maternal health and prevent perinatal transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. A Preparedness Model for Mother–Baby Linked Longitudinal Surveillance for Emerging Threats.
- Author
-
Woodworth, Kate R., Reynolds, Megan R., Burkel, Veronica, Gates, Cymone, Eckert, Valorie, McDermott, Catherine, Barton, Jerusha, Wilburn, Amanda, Halai, Umme-Aiman, Brown, Catherine M., Bocour, Angelica, Longcore, Nicole, Orkis, Lauren, Lopez, Camille Delgado, Sizemore, Lindsey, Ellis, Esther M., Schillie, Sarah, Gupta, Neil, Bowen, Virginia B., and Torrone, Elizabeth
- Subjects
- *
HEPATITIS C , *INFANT health services , *MATHEMATICAL models , *MEDICAL records , *PREGNANCY complications , *PUBLIC health surveillance , *SYPHILIS , *THEORY , *RETROSPECTIVE studies , *VERTICAL transmission (Communicable diseases) , *ACQUISITION of data methodology , *COVID-19 , *PREGNANCY outcomes - Abstract
Introduction: Public health responses often lack the infrastructure to capture the impact of public health emergencies on pregnant women and infants, with limited mechanisms for linking pregnant women with their infants nationally to monitor long-term effects. In 2019, the Centers for Disease Control and Prevention (CDC), in close collaboration with state, local, and territorial health departments, began a 5-year initiative to establish population-based mother–baby linked longitudinal surveillance, the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET). Objectives: The objective of this report is to describe an expanded surveillance approach that leverages and modernizes existing surveillance systems to address the impact of emerging health threats during pregnancy on pregnant women and their infants. Methods: Mother–baby pairs are identified through prospective identification during pregnancy and/or identification of an infant with retrospective linking to maternal information. All data are obtained from existing data sources (e.g., electronic medical records, vital statistics, laboratory reports, and health department investigations and case reporting). Results: Variables were selected for inclusion to address key surveillance questions proposed by CDC and health department subject matter experts. General variables include maternal demographics and health history, pregnancy and infant outcomes, maternal and infant laboratory results, and child health outcomes up to the second birthday. Exposure-specific modular variables are included for hepatitis C, syphilis, and Coronavirus Disease 2019 (COVID-19). The system is structured into four relational datasets (maternal, pregnancy outcomes and birth, infant/child follow-up, and laboratory testing). Discussion: SET-NET provides a population-based mother–baby linked longitudinal surveillance approach and has already demonstrated rapid adaptation to COVID-19. This innovative approach leverages existing data sources and rapidly collects data and informs clinical guidance and practice. These data can help to reduce exposure risk and adverse outcomes among pregnant women and their infants, direct public health action, and strengthen public health systems. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. Notes from the Field: Acute Hepatitis A Virus Infection Among Previously Vaccinated Persons with HIV Infection - Tennessee, 2018.
- Author
-
Brennan, Julia, Moore, Kelly, Sizemore, Lindsey, Mathieson, Samantha A., Wester, Carolyn, Dunn, John R., Schaffner, William, and Jones, Timothy F.
- Subjects
- *
HIV infections , *VIRAL hepatitis , *VIRUS diseases , *HEPATITIS B vaccines , *HEPATITIS A vaccines - Abstract
The article reports on the prevalence of acute Hepatitis A virus infection among previously vaccinated persons with HIV infection in Tennessee in 2018. The Tennessee Department of Health (TDH) examined the frequency at which the patients developed Hepatitis A virus infection. The Centers for Disease Control and Prevention (CDC) investigated the effect of monovalent vaccines and immune globulins (IG) on the patients.
- Published
- 2019
- Full Text
- View/download PDF
18. Pregnancy Status, Risk Factors, and Opportunities for Referral to Care Among Reproductive-Aged Women With Newly Reported Chronic Hepatitis C Virus Infection in Tennessee.
- Author
-
Oliver, Cassandra, Black, Jennifer, De Pont, Shannon, Sizemore, Lindsey, and Wester, Carolyn
- Subjects
- *
INTRANASAL medication , *COUNSELING , *MATERNAL age , *MATERNAL health services , *PRISONERS , *MEDICAL referrals , *PUBLIC health surveillance , *SUBSTANCE abuse , *WOMEN'S health , *PATIENTS' attitudes , *CHRONIC hepatitis C , *DISEASE risk factors , *PREGNANCY - Abstract
Objectives: From 2006 through 2012, the number of acute hepatitis C virus (HCV) infections increased 364% among persons aged ≤30, including reproductive-aged women, in Central Appalachian states. Outreach to reproductive-aged women with newly diagnosed HCV infection affords a unique opportunity to provide counseling, further testing, and linkage to treatment. We modeled a centrally located statewide effort to reach this population and their health care providers to ascertain pregnancy status, HCV risk factors, and opportunities for linkage to additional services. Methods: Using the Tennessee Department of Health's surveillance database, we identified women aged 18-45 residing in Tennessee with newly reported chronic HCV infection from May through October 2017. We contacted health care providers and patients to request information on pregnancy status and HCV risk factors as well as to provide linkage to treatment services. Results: Of 1548 women included in this study, health care provider or patient contact information was available for 1316 (85.0%) women. Of the 1316 women, 806 (61.2%) women had a health care provider or patient response, of whom 242 (30.0%) were pregnant. Of 296 patients contacted, 194 (65.5%) reported intranasal drug use, 193 (65.2%) reported having been incarcerated for more than 24 hours, and 180 (60.8%) reported injection drug use. Ninety-eight (33.1%) patients were referred for confirmatory testing, and 174 (58.8%) were referred to treatment. Conclusion: A high proportion of reproductive-aged women with newly diagnosed HCV infection were pregnant. Surveillance-informed outreach to this population was feasible and provided opportunities for counseling and linkage to confirmatory testing and treatment. Future studies should evaluate whether a similar model would enhance testing and linkage to care of HCV-exposed infants. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.